Digital Health Europe

DIAMONDS (Digital Assisted Monitoring for Diabetes): a telemedicine and web-based system for self monitoring of diabetes

Keywords: (Clinical) Decision Support Services, Diabetes, Self-Monitoring, Telemedicine
Type
Digital solution and service (e.g. application/digital health portal/platform/AI based system/etc.)
Short description
The practice aims to validate the clinical efficacy of a telemedicine- and web-based system platform for self-monitoring of blood glucose (SMBG) data transmission and analysis of metabolic control, assessed by measuring changes inHbA1c, in insulin-treated diabetic patients. The system platform involves (i.) systematic (real-time and anywhere) transmission of SMBG data to a decision supported software (DSS)-assisted server, (ii.) web-based analysis of data, and (iii.) feedback on patients and medical staff to implement metabolic control. Additional aims include assessments of patients’ adherence to perform SMBG, analysis of the specific and overall quality of glucose control, identification of situations predictive of hypoglycemic and/or hyperglycemic episodes, and detection of episodes of hypoglycemia and sustained hyperglycemia. It is to be expected that use of the telemedicine- and web-bases system platform will result in improved metabolic control as compared with standard of care, as shown by a greater decrease in HbA1c from baseline. In addition, it will potentially result in better quality of glucose monitoring and control (e.g., appropriateness of SMBG testing, glucose excursions, indexes of glucose variability) and frequency and severity of hypoglycemic episodes. Also, quality of life should be improved in the telemedicine group. Thus, patients and physicians will be provided with a tool that allows to verify the appropriateness of SMBG in relation to the diabetes status, and this will be also relevant to “payers” (false glucose reporting and data collection will be avoided, patient/physician interaction will be optimized while limiting the number of medical visits).
Evidence
Impact on health outcomes, Economic value to health and care systems
Maturity
There is evidence for economic viability and/or of benefits to the target group of the practice. Further research/development is needed for routine use.
Countries
Italy
Apulia
Geographical scope
Regional
Language(s)
Italian
Comment
People reached: 10,000-99,999
Submitted in other database or repository of digital health resources that is publicly available
https://digitalhealtheurope.eu/catalogue/, DHE catalogue

Additional information

Relations
to clinicians / care practitioners
Clinical decision support
to patients / citizens
Sensors/wearable devices
Telehealth and telemedicine
Self-management/ICT supporting adherence to medication and care-plans
Primary target patient group (age)
May be used across all patient ages
Use case and care pathway positioning
Disease monitoring, treatment compliance, self-management
Ready to be transferred to
Ready for transfer, but the practice has not been transferred yet.